Effect of vitamin E in nonalcoholic fatty liver disease with metabolic syndrome: A propensity score-matched cohort study
Gi Hyun Kim, Jung Wha Chung, Jong Ho Lee, Kyeong Sam Ok, Eun Sun Jang, Jaihwan Kim, Cheol Min Shin, Young Soo Park, Jin-Hyeok Hwang, Sook-Hyang Jeong, Nayoung Kim, Dong Ho Lee, Jin-Wook Kim
Clin Mol Hepatol. 2015;21(4):379-386. Published online 2015 Dec 24 DOI: https://doi.org/10.3350/cmh.2015.21.4.379
Citations to this article as recorded by 
Allium sativum: A potential natural compound for NAFLD prevention and treatment
Parham Mardi, Reza Kargar, Ramina Fazeli, Mostafa Qorbani
Frontiers in Nutrition.2023;[Epub] CrossRef
Exploring the Impact of Nutrition on Non-Alcoholic Fatty Liver Disease Management: Unveiling the Roles of Various Foods, Food Components, and Compounds
Marcin Kosmalski, Rafał Frankowski, Kacper Deska, Monika Różycka-Kosmalska, Tadeusz Pietras
Nutrients.2023; 15(13): 2838. CrossRef
Effect of Vitamin E on Clinical Outcomes in Patients With Non-alcoholic Fatty Liver Disease: A Meta-Analysis
Jithin Karedath, Hiba Javed, Fatima Ahsan Talpur, Bihari Lal, Anmol Kumari, Husam Kivan, Venkata Anirudh Chunchu, Shamsha Hirani
Cureus.2022;[Epub] CrossRef
Current innovations in nutraceuticals and functional foods for intervention of non-alcoholic fatty liver disease
Mengyao Zhao, Shumin Chen, Xiaoguo Ji, Xin Shen, Jiangshan You, Xinyi Liang, Hao Yin, Liming Zhao
Pharmacological Research.2021; 166: 105517. CrossRef
Can vitamin E supplementation affect obesity indices? A systematic review and meta-analysis of twenty-four randomized controlled trials
Mohammad Reza Emami, Sanaz Jamshidi, Meysam Zarezadeh, Masoud Khorshidi, Beheshteh Olang, Zohreh Sajadi Hezaveh, Mohammadhassan Sohouli, Naheed Aryaeian
Clinical Nutrition.2021; 40(5): 3201. CrossRef
Use of a bioengineered antioxidant in mouse models of metabolic syndrome
Deric M. Griffin, Brittany R. Bitner, Zachary Criss Ii, Daniela Marcano, Jacob M. Berlin, Thomas A. Kent, James M. Tour, Susan L. Samson, Robia G. Pautler
Expert Opinion on Investigational Drugs.2020; 29(2): 209. CrossRef
VII. The Evidence of Pharmacologic Treatment for NASH
Masashi Yoneda
Nihon Naika Gakkai Zasshi.2020; 109(1): 56. CrossRef
Gamma-tocopherol ameliorates hyperglycemia-induced hepatic inflammation associated with NLRP3 inflammasome in alloxan-induced diabetic mice
Heaji Lee, Yunsook Lim
Nutrition Research and Practice.2019; 13(5): 377. CrossRef
Effect of vitamin E in non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomised controlled trials
Iram Amanullah, Yusra Habib Khan, Iqraa Anwar, Aqsa Gulzar, Tauqeer Hussain Mallhi, Ahsan Aftab Raja
Postgraduate Medical Journal.2019; 95(1129): 601. CrossRef
Haptoglobin Genotype and Vitamin E Versus Placebo for the Treatment of Nondiabetic Patients with Nonalcoholic Steatohepatitis in China: A Multicenter, Randomized, Placebo-Controlled Trial Design
Shufei Zang, Jin Chen, Yu Song, Lang Bai, Jinjun Chen, Xiaoling Chi, Fangping He, Huiping Sheng, Jing Wang, Shilong Xie, Wen Xie, Yongfeng Yang, Jing Zhang, Minghua Zheng, Zhengsheng Zou, Bingyuan Wang, Junping Shi
Advances in Therapy.2018; 35(2): 218. CrossRef
An Overview of Novel Dietary Supplements and Food Ingredients in Patients with Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease
Priscila Silva Figueiredo, Aline Inada, Melina Ribeiro Fernandes, Daniela Granja Arakaki, Karine Freitas, Rita Avellaneda Guimarães, Valter Aragão do Nascimento, Priscila Aiko Hiane
Molecules.2018; 23(4): 877. CrossRef